SPHERA FUNDS MANAGEMENT LTD.

Position in BIOA — BioAge Labs, Inc.

CIK 1496201 TEL AVIV, L3

Position in BIOA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,513,199

-$1,702,154 QoQ

Shares Held

86,518

-64.4% QoQ

Ownership

0.195%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $45,311,123 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,136,975	$34,245,687
2	BCRX	Biocryst Pharmaceuticals Inc	866,464	$8,248,737
3	BIOA	BioAge Labs, Inc. This page	86,518	$1,513,199
4	ORGO	Organogenesis Holdings Inc.	550,000	$1,303,500

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,513,199	86,518	-64.4%	Shares	Defined	2026-05-15
2025-12-31	$3,215,353	243,035	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.